Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Valaris Limited Common Shares (VAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Valaris Limited Common Shares — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Valaris Limited Common Shares trades at $84.6 (market cap $5.94B). The key difference: Oruka Therapeutics Inc. Common Stock and Valaris Limited Common Shares are close in size by market cap, and Valaris Limited Common Shares is more actively traded (742,554 versus 490,798). Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Valaris Limited Common Shares for 0 Days on average.
| ORKA | VAL | |
|---|---|---|
Market Cap | $5.18B | $5.94B |
Volume | 490,798 | 742,554 |
Sector | Health | Energy |
52-Week High | $113.08 | $113.42 |
52-Week Low | $26.19 | $48.15 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $6.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Valaris Limited Common Shares
Valaris Limited provides offshore contract drilling services to the oil and gas industry, operating a fleet of drillships, semisubmersibles, and jackup rigs across multiple regions worldwide.
Read more on VAL →
